<?xml version="1.0" encoding="UTF-8"?>
<fig id="nanomaterials-10-01072-f005" orientation="portrait" position="float">
 <label>Figure 5</label>
 <caption>
  <p>The onset of the clinical vaccineâ€™s development against massive outbreaks. Ad4, 5, or 26 vectors (human adenovirus type 4, 5, or 26); ChAd (chimpanzee adenovirus); MVA (modified vaccinia Ankara); VSV (vesicular stomatitis virus); HPIV3 (human parainfluenza virus type 3); MV (measles virus). Redrawn with permission from [
   <xref rid="B72-nanomaterials-10-01072" ref-type="bibr">72</xref>], an open access article (CC BY).
  </p>
 </caption>
 <graphic xlink:href="nanomaterials-10-01072-g005" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
